BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

570 hedge funds and large institutions have $10.1B invested in BioMarin Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 237 increasing their positions, 182 reducing their positions, and 82 closing their positions.

Holders
570
Holders Change
-9
Holders Change %
-1.55%
% of All Funds
7.66%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.09%
New
85
Increased
237
Reduced
182
Closed
82
Calls
$57.8M
Puts
$56.6M
Net Calls
+$1.24M
Net Calls Change
-$8.78M

Top Buyers

1
AQR Capital Management
1
AQR Capital Management
Connecticut
$306M
2
Millennium Management
2
Millennium Management
New York
$156M
3
Norges Bank
3
Norges Bank
Norway
$112M
4
Viking Global Investors
4
Viking Global Investors
Connecticut
$676M
5
Morgan Stanley
5
Morgan Stanley
New York
$134M

Top Sellers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$21.5M
2
EIM
2
Elliott Investment Management
Florida
$0
3
Ameriprise
3
Ameriprise
Minnesota
$119M
4
Primecap Management
4
Primecap Management
California
$867M
5
NL
5
Nuveen LLC
North Carolina
$40.5M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$1.32B 24,001,675 +222,676 +0.9%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.04B 19,003,832 +620 +0%
Primecap Management
3
Primecap Management
California
$867M 15,772,173 -2,001,108 -11%
Dodge & Cox
4
Dodge & Cox
California
$831M 15,108,310 +153,070 +1%
Viking Global Investors
5
Viking Global Investors
Connecticut
$676M 12,288,611 +1,488,552 +14%
State Street
6
State Street
Massachusetts
$486M 8,847,751 +384,661 +5%
AQR Capital Management
7
AQR Capital Management
Connecticut
$306M 5,580,573 +2,654,768 +91%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$190M 3,474,438 +43,185 +1%
Millennium Management
9
Millennium Management
New York
$156M 2,834,355 +2,159,083 +320%
Morgan Stanley
10
Morgan Stanley
New York
$134M 2,428,689 +1,385,804 +133%
Ameriprise
11
Ameriprise
Minnesota
$119M 2,161,172 -2,046,391 -49%
Goldman Sachs
12
Goldman Sachs
New York
$116M 2,105,605 +512,642 +32%
Norges Bank
13
Norges Bank
Norway
$112M 2,043,879 +2,043,879 New
Renaissance Technologies
14
Renaissance Technologies
New York
$99.3M 1,806,771 +911,000 +102%
UBS Group
15
UBS Group
Switzerland
$93.2M 1,695,593 +1,579 +0.1%
Squarepoint
16
Squarepoint
New York
$91.9M 1,672,447 +283,719 +20%
Northern Trust
17
Northern Trust
Illinois
$91M 1,655,111 -41,753 -2%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$86.5M 1,573,620 +406,125 +35%
Charles Schwab
19
Charles Schwab
California
$85.5M 1,556,117 +23,803 +2%
Man Group
20
Man Group
United Kingdom
$81.2M 1,476,922 +672,628 +84%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$75.1M 1,365,581 -12,983 -0.9%
UBS AM
22
UBS AM
Illinois
$72.5M 1,319,792 +254,868 +24%
DnB Asset Management
23
DnB Asset Management
Norway
$61.5M 1,119,330 +127,844 +13%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$61.3M 1,115,428 +569,653 +104%
Pictet Asset Management
25
Pictet Asset Management
Switzerland
$60.1M 1,093,378 +808,078 +283%
1
2 3 4 5